Asynchronous programming with async and await has existed in .NET for years. Now Microsoft is delivering a new runtime environment for asynchronous execution. Dr. Holger Schwichtenberg is Chief ...

AI-native platform adds enterprise SSO capabilities across 25+ identity providers to existing authentication infrastructure without migration. SAN FRANCISCO, CA, UNITED STATES, Ma ...

The Resurgence Core is the final boss in Code Vein 2. This battle occurs during the hidden Rescue Lou quest and can only be accessed after completing all of the Timeline Shift Decision quests. This ...

My first jet approach was nothing like I expected Posted: February 16, 2026 | Last updated: February 16, 2026 There is nothing quite like the first time you line up a jet on final. The speed is higher ...

Japan’s firebrand prime minister, Sanae Takaichi, and her Liberal Democratic Party won a decisive victory in Sunday’s snap elections, according to public broadcaster NHK, securing a robust ...

It's been a busy week for the Cleveland Browns. On top of announcing Todd Monken as the 19th head coach in franchise history, the former Baltimore Ravens offensive coordinator has made a flurry of ...

How Chinese is your car? Automakers are racing to work it out. Modern cars are packed with internet-connected widgets, many of them containing Chinese technology. Now, the car industry is scrambling ...

Google has released the February 2026 Discover core update, which focuses specifically on how content is surfaced in Google Discover. Google said the update is rolling out first to English-language ...

MADISON(WKOW) — Microsoft is pledging to address concerns related to data centers, such as energy prices and water use, as it plans to build 15 new centers in Mount Pleasant. Earlier this year, the ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

As the first CAR-T treatment for an autoimmune disease draws ever closer, officials at the FDA have signaled a willingness to support the development of these novel cell therapies with a flexible ...